The race to develop the next generation of weight loss drugs has taken an interesting new turn. In recent research, Eli Lilly ...

The retrospective phase 2b study, which explored the use of various non-invasive tests (NITs) to assess response to semaglutide, adds to growing evidence that the drug not only improves metabolic ...

A new international clinical trial has shown that the oral form of semaglutide, a medication already known for managing type ...

Peptides represent one of the most exciting frontiers in wellness right now. They’re powerful, in-demand, and full of ...

Novo Nordisk A/S remains attractive with strong cash flow and robust pipeline. Click here to read why NVO stock is a Buy.

At the American Association for the Study of Liver Diseases (AASLD) annual meeting, a session highlighted new guidance on ...

No significant increase in hazard ratios seen for GI events for semaglutide versus dulaglutide, tirzepatide versus dulaglutide, tirzepatide versus semaglutide.

Today, we're diving into a hot topic in the world of health and wellness: semaglutide. You might have heard about this ...

Experts say we’re in a golden age for treating chronic kidney disease, with new drugs like Ozempic yielding major results.

Nearly 1 in 5 people with metabolic dysfunction-associated steatohepatitis and compensated cirrhosis were prescribed a GLP-1 ...

Obesity is one of the biggest barriers preventing patients with end-stage kidney disease from receiving a life-saving kidney ...

New research reveals that tirzepatide and semaglutide both offer strong, early heart-protective effects. A major new ...